|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 129.11 USD | +4.00% |
|
+4.06% | +5.19% |
| Capitalization | 160B 137B 127B 119B 221B 14,673B 237B 1,459B 577B 6,934B 601B 588B 25,330B | P/E ratio 2025 * |
19.3x | P/E ratio 2026 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise value | 173B 148B 137B 129B 239B 15,852B 256B 1,576B 624B 7,492B 649B 636B 27,366B | EV / Sales 2025 * |
5.92x | EV / Sales 2026 * | 5.5x |
| Free-Float |
99.9% | Yield 2025 * |
2.57% | Yield 2026 * | 2.7% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +4.00% | ||
| 1 week | +4.06% | ||
| Current month | +5.19% | ||
| 1 month | +3.88% | ||
| 3 months | +4.05% | ||
| 6 months | +19.24% | ||
| Current year | +5.19% |
| 1 week | 122.1 |  | 129.39 |
| 1 month | 116.88 | | 129.39 |
| Current year | 116.88 | | 129.39 |
| 1 year | 92.21 | | 129.39 |
| 3 years | 62.07 | | 129.39 |
| 5 years | 57.16 | | 129.39 |
| 10 years | 56.56 | | 129.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 60 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Dietmar Berger
CTO | Chief Tech/Sci/R&D Officer | 64 | 02/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
| Director/Board Member | 72 | 09/05/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -3.68% | 13.99% | 253 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.00% | +4.06% | +38.89% | +55.54% | 160B | |
| +3.58% | +0.49% | +45.28% | +211.65% | 966B | |
| -0.09% | -0.25% | +47.15% | +29.20% | 525B | |
| +0.99% | -2.59% | +25.22% | +44.49% | 382B | |
| -0.38% | +1.11% | +29.15% | +17.13% | 371B | |
| -1.35% | -4.78% | +23.57% | +19.09% | 278B | |
| +0.07% | +0.62% | +28.14% | +35.35% | 276B | |
| -4.02% | -2.47% | -32.19% | -22.60% | 260B | |
| +1.52% | +0.09% | +15.45% | +1.06% | 276B | |
| +3.81% | +4.45% | +25.03% | +30.53% | 185B | |
| Average | +0.34% | -0.33% | +24.57% | +42.14% | 367.94B | |
| Weighted average by Cap. | -0.14% | -0.48% | +29.90% | +72.60% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 29.22B 24.98B 23.19B 21.75B 40.35B 2,676B 43.21B 266B 105B 1,265B 110B 107B 4,620B | 30.19B 25.81B 23.96B 22.47B 41.69B 2,765B 44.64B 275B 109B 1,307B 113B 111B 4,774B |
| Net income | 8.03B 6.87B 6.37B 5.98B 11.09B 736B 11.88B 73.15B 28.95B 348B 30.12B 29.5B 1,270B | 8.92B 7.63B 7.08B 6.64B 12.32B 817B 13.2B 81.29B 32.17B 386B 33.47B 32.78B 1,411B |
| Net Debt | 12.88B 11.01B 10.22B 9.58B 17.78B 1,179B 19.04B 117B 46.41B 557B 48.29B 47.3B 2,036B | 5.75B 4.91B 4.56B 4.28B 7.94B 526B 8.5B 52.36B 20.72B 249B 21.55B 21.11B 909B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/01/26 | 129.11 $ | +4.00% | 7,285,253 |
| 20/01/26 | 124.14 $ | -0.62% | 9,152,643 |
| 16/01/26 | 124.91 $ | +3.01% | 10,639,074 |
| 15/01/26 | 121.26 $ | -2.26% | 6,659,785 |
| 14/01/26 | 124.07 $ | +1.90% | 4,659,420 |
Delayed Quote Nasdaq, 22 January 2026 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition